PAIGE

New York, United States Founded: 2018 • Age: 8 yrs Acquired By Tempus
AI-enabled tools for computational pathology and cancer diagnostics are provided.

About PAIGE

PAIGE is a Healthcare company based in New York (United States) founded in 2018 by David Klimstra and Thomas Fuchs, and was acquired by Tempus in August 2025. AI-enabled tools for computational pathology and cancer diagnostics are provided. It operates in the Healthcare and Technology sectors. PAIGE has raised $241 million across 8 funding rounds from investors including Microsoft, Goldman Sachs and Tempus. Its chief executive, as recorded, is Razik Yousfi. Its website paige.ai draws about 21 thousand monthly visits. PAIGE offers products and services including Paige Prostate Suite, Paige Breast Suite, Paige GI Suite, and Paige Alba. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Image Analysis. Its legal entity is PAIGE AI, INC. Its competitors include PathAI, Viz.ai and Deepcell; 3 of its 3 listed competitors have raised funding.

Company details

Founded in 2018 and based in New York, United States, the company operates in the healthcare technology sector, specializing in AI-driven computational pathology. Deep learning algorithms, utilizing convolutional and recurrent neural networks, are applied to analyze visual and clinical data for cancer diagnosis and treatment. Products such as FullFocus support pathology workflows, while PAIGE.AI aids in patient stratification and biomarker development for treatment planning.

  • Headquarters New York, United States
  • Founders David Klimstra, Thomas Fuchs
  • Stage Acquired
  • Sectors
    Healthcare
    Technology
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website paige.ai
  • Social LinkedIn X
  • Acquired by Tempus (Aug 2025)
  • Legal Name Paige Ai, Inc
Key Metrics
  • Total Equity Funding
    $241M (USD)

    in 8 rounds

  • Latest Funding Round
    $19.5M (USD), Series C

    Jan 2023

  • Investors
    Microsoft

    & 11 more

  • Acquired by
    Tempus

    (Aug 2025)

Products & Services of PAIGE

PAIGE offers a comprehensive portfolio of products and services, including Paige Prostate Suite, Paige Breast Suite, Paige GI Suite, and Paige Alba.

Paige Prostate Suite
Diagnostic AI

AI for detecting and diagnosing prostate cancer on tissue images

Paige Breast Suite
Diagnostic AI

AI applications for breast cancer identification and classification

Paige GI Suite
Diagnostic AI

AI tools for gastrointestinal cancer detection and classification

Paige Alba
AI Co-Pilot

Multi-modal tool to streamline pathology workflows and diagnostics

Funding Insights of PAIGE

PAIGE has successfully raised a total of $241M across 8 strategic funding rounds. The most recent funding activity was a Series C round of $19.5 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $241M
  • Total Rounds 8
  • Last Round Series C β€” $19.5M
  • First Round $25M

    (Feb 2018)

  • Investors Count 11

All 8 funding rounds of PAIGE with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2023$19.5MSeries C–Microsoft
–
Mar 2021$25MSeries C–KKR, Casdin Capital
Jan 2021$100MSeries C–Johnson & Johnson Innovation – JJDC, Casdin Capital
–
Jul 2020$20MSeries B–Goldman Sachs
Apr 2020$5MSeries B–Goldman Sachs
–
Dec 2019$45MSeries B–Healthcare Ventures
Apr 2019$1.5MSeed––
Feb 2018$25MSeries A–Jim Breyer
–
Valuation history

12 investors in total: 10 institutional and 2 angel.

Investors in PAIGE

PAIGE has secured backing from 12 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Microsoft, Goldman Sachs and Tempus.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Venture capital firm backed by Johnson & Johnson
jnjinnovation.com/jjdcCambridge, United States
Investing in Life Sciences sectors like Healthcare and Biotechnology.
casdincapital.com
Investment banking services are delivered across multiple financial sectors.
1869goldmansachs.comNew York, United States
hcven.com
Venture capital firm
breyercapital.comMenlo Park, United States
Multiple sectors are invested in by this private equity firm.
1976kkr.comNew York, United States
Venture capital is provided to biomedical technology startups.
cataliocapital.comNew York, United States
Venture capital funding is provided to early-stage startups.
geekdomfund.com
Microsoft is recognized for software, hardware, and gaming solutions.
1975microsoft.comRedmond, United States

Kenan Turnacioglu

Angel investor and entrepreneur, co-founder of Gram Games, active in tech startups
unknown_61c8951b6dde4467a
Premium access

Investor details for PAIGE

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of PAIGE

48 people are tracked at PAIGE (14 in leadership, 18 in board & advisors, 16 in team).

NameRoleGroup
David Klimstra
Co-FounderLeadership
Thomas Fuchs
Co-FounderLeadership
Razik Yousfi
CEO & CTOLeadership
Jason Lewis
Sales DirectorLeadership
Alexis Ahiekpor-Dravi
Director Of AI EngineeringLeadership
Jennifer Andreasson
Director of Technical OperationsLeadership
David S. Klimstra
Founder, Chief ScientistLeadership
Gerard Slootweg
VP of SalesLeadership
Juan Retamero
Medical Vice PresidentLeadership
Peter Hamilton
Chief Operational OfficerLeadership
Djamilia Dierov, MPH
Vice President Of Business Development & PartnershipsLeadership
Caitlin McWilliams
VP Of Finance And Corporate DevelopmentLeadership
Chris Kanan
Director, AI ScientistLeadership
Mike Kramer
VP of Pathology & Medical Services, Quest DiagnosticsLeadership
Kenan Turnacioglu
Board ChairmanBoard & advisors
David Rimm
Member, Advisory BoardBoard & advisors
Eli Casdin
Board MemberBoard & advisors
John Iafrate
Member, Advisory BoardBoard & advisors
Asish K. Xavier
Member Board Of DirectorsBoard & advisors
Jefrey C. Lightcap
Board MemberBoard & advisors

28 more people are available in the full profile.

Premium access

Complete people profiles for PAIGE

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of PAIGE

4 dated milestones of PAIGE across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded PAIGE is founded.
  2. Funding First funding round of $25.0M.
  3. Funding Latest funding round, Series C, of $19.5M.
  4. Exit Acquired by Tempus.

Competitors of PAIGE

PAIGE has 3 listed competitors in our database, 3 of them funded. They include PathAI, Viz.ai and Deepcell.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
pathai.com2016Boston, United States$254.94M573
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
viz.ai2016San Francisco, United States$251.99M206
AI and cloud-powered software for stroke care coordination is developed.
deepcell.com2015Mountain View, United States$122.99M94
AI-powered single cell classification and isolation technology for clinical research
Premium access

Detailed competitors of PAIGE

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of PAIGE

The website of PAIGE (paige.ai) receives about 20.8K visits a month.

  • Monthly visits
    20.8K

    ▼ 8.1% vs previous month

Similar websites

Websites whose visitors overlap most with PAIGE. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
cardmaillouisville-my.sharepoint.com
cardmaillouisville-my.sharepoint.com
100%
–
pageai.co
50%
9.4K#2,629,693View details

Top companies in Healthcare Provider Support Services

3 companies that operate in the same segment as PAIGE (Healthcare Provider Support Services) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of self funded health plan
2017New York, New York, United StatesUSD 224 M212
Provider of AI solutions for clinical, operational, and business outcomes
2005Princeton, New Jersey, United StatesUSD 1.13 BUSD 465.22 M5,442
AMN Healthcare is recognized as a leading healthcare staffing provider.
1985San Diego, California, United StatesUSD 2.73 B2,970
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Paige

Premium access

Complete news archive for PAIGE

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about PAIGE

PAIGE was founded in 2018.

PAIGE is headquartered in New York, United States. It is registered at New York, New York, United States.

Razik Yousfi is the CEO of PAIGE, as recorded in our data.

PAIGE is a funded company, having raised a total of $241M across 8 funding rounds to date. The company's 1st funding round was a Series A of $25M, raised on Feb 2018.

Founded in 2018 and based in New York, United States, the company operates in the healthcare technology sector, specializing in AI-driven computational pathology. Deep learning algorithms, utilizing convolutional and recurrent neural networks, are applied to analyze visual and clinical data for cancer diagnosis and treatment. Products such as FullFocus support pathology workflows, while PAIGE.AI aids in patient stratification and biomarker development for treatment planning.

PAIGE's top competitors include PathAI, Viz.ai and Deepcell.

PAIGE offers Paige Prostate Suite, Paige Breast Suite, Paige GI Suite, and Paige Alba.

PAIGE has 12 investors. Key investors include Microsoft, Goldman Sachs, Tempus, KKR, and Johnson & Johnson Innovation – JJDC.

PAIGE operates through Paige Ai, Inc.

Yes. PAIGE was acquired by Tempus in August 2025.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available